The Story So Far: The UK’s New Licensing And Access Pathway
More Than 35 'Innovation Passports' Have Been Issued
As the UK’s new pathway for innovative drugs approaches the end of its first year of operation, representatives of the national regulatory agency and England’s HTA body assess progress so far, including the greater role assigned to patients in the system.
